Objective： To investigate the clinical efficacy of intraperitoneal chemotherapy before surgery for ovarian cancer. Methods： 60 patients with stages Ⅱ-Ⅳ of ovarian cancer were treated with intraperitoneal chemother...Objective： To investigate the clinical efficacy of intraperitoneal chemotherapy before surgery for ovarian cancer. Methods： 60 patients with stages Ⅱ-Ⅳ of ovarian cancer were treated with intraperitoneal chemotherapy of CAP or TP regimen followed by a surgery treatment and another chemotherapy for 6 cycles. And then the efficiency of the therapy was evaluated by analyzing the changes of ascites, the serum CA-125 and CA-19-9 levels and the findings in the operation, and investigating the recurrence of cancer and the survival. Results： After 1-3 cycles of intraperitoneal chemotherapy, serum levels of CA-125 and CA-19-9 and carcinous ascites significantly reduced in all patients, ascites reduce was over 50% in 98.3% cases; all cases were successfully treated with cytoreduction and it was found during the operation that bulky tumor was reduced and looser so as to be easily isolated and removed; PFS of the patients was prolonged, while the toxicity and side-effects were not so serious as beyond the patient toleration. Conclusion： Intraperitoneal chemotherapy before surgery for ovarian cancer has an active efficacy in clinic, being able to improve conditions of surgery and increase the opportunity of maximal cytoreduction, and prolong survival of the patients, and should be a good selection for the treatment of advanced ovarian cancer.展开更多
Ovarian cancer is one of the most common gynecological malignancies and can occur at any time in a woman's life.This paper analyzed the etiology and pathogenesis of ovarian cancer in traditional Chinese medicine,a...Ovarian cancer is one of the most common gynecological malignancies and can occur at any time in a woman's life.This paper analyzed the etiology and pathogenesis of ovarian cancer in traditional Chinese medicine,and simply sorted out the methods and means of oral administration and external application of traditional Chinese medicine in the treatment of ovarian cancer,hoping to provide new therapeutic ideas for the treatment of the disease.展开更多
文摘Objective： To investigate the clinical efficacy of intraperitoneal chemotherapy before surgery for ovarian cancer. Methods： 60 patients with stages Ⅱ-Ⅳ of ovarian cancer were treated with intraperitoneal chemotherapy of CAP or TP regimen followed by a surgery treatment and another chemotherapy for 6 cycles. And then the efficiency of the therapy was evaluated by analyzing the changes of ascites, the serum CA-125 and CA-19-9 levels and the findings in the operation, and investigating the recurrence of cancer and the survival. Results： After 1-3 cycles of intraperitoneal chemotherapy, serum levels of CA-125 and CA-19-9 and carcinous ascites significantly reduced in all patients, ascites reduce was over 50% in 98.3% cases; all cases were successfully treated with cytoreduction and it was found during the operation that bulky tumor was reduced and looser so as to be easily isolated and removed; PFS of the patients was prolonged, while the toxicity and side-effects were not so serious as beyond the patient toleration. Conclusion： Intraperitoneal chemotherapy before surgery for ovarian cancer has an active efficacy in clinic, being able to improve conditions of surgery and increase the opportunity of maximal cytoreduction, and prolong survival of the patients, and should be a good selection for the treatment of advanced ovarian cancer.
基金Supported by Guangxi Science and Technology Base and Talent Project(GK AD21238031)Guangxi Key Research and Development Program(GK AB21196016)+8 种基金Collaborative Innovation Center of Zhuang and Yao Ethnic Medicine(GJKY[2013]20)Guangxi Key Laboratory of Zhuang and Yao Ethnic Medicine(GKJZ[2014]32)Guangxi Ethnic Medicine Resources and Application Research Center of Engineering(GFGGJH[2020]2605)Guangxi Key Discipline:Zhuang Ethnic Medicine(GZXK-Z-20-64)The Eighth Batch of Special Expert Projects of Guangxi Zhuang Autonomous Region(GRCTZ[2019]13)National Natural Science Foundation of China(82060695)Guangxi Zhuang Autonomous Region Philosophy and Social Science Planning Research Project(20BMZ005)Foreign Expert Project of the Ministry of Science and Technology of the People's Republic of China(GXL20200233001)Guangxi First-class Discipline of Traditional Chinese Medicine:Ethnic Medicine(GJKY[2018]12)。
文摘Ovarian cancer is one of the most common gynecological malignancies and can occur at any time in a woman's life.This paper analyzed the etiology and pathogenesis of ovarian cancer in traditional Chinese medicine,and simply sorted out the methods and means of oral administration and external application of traditional Chinese medicine in the treatment of ovarian cancer,hoping to provide new therapeutic ideas for the treatment of the disease.
